KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeMD (LFMD) Gross Margin (2016 - 2025)

LifeMD filings provide 14 years of Gross Margin readings, the most recent being 40.22% for Q4 2025.

  • On a quarterly basis, Gross Margin rose 6419.0% to 40.22% in Q4 2025 year-over-year; TTM through Dec 2025 was 29.95%, a 5609.0% decrease, with the full-year FY2025 number at 85.72%, down 43.0% from a year prior.
  • Gross Margin hit 40.22% in Q4 2025 for LifeMD, down from 87.69% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 90.59% in Q3 2024 to a low of 23.97% in Q4 2024.
  • Median Gross Margin over the past 5 years was 84.88% (2022), compared with a mean of 69.17%.
  • Biggest five-year swings in Gross Margin: tumbled -11203bps in 2024 and later surged 6419bps in 2025.
  • LifeMD's Gross Margin stood at 79.69% in 2021, then increased by 7bps to 85.53% in 2022, then increased by 3bps to 88.06% in 2023, then crashed by -127bps to 23.97% in 2024, then soared by 268bps to 40.22% in 2025.
  • The last three reported values for Gross Margin were 40.22% (Q4 2025), 87.69% (Q3 2025), and 0.93% (Q2 2025) per Business Quant data.